Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.

OBJECTIVE The objective was to determine the circadian rhythm of melatonin in the Smith-Magenis syndrome (SMS), which causes behavioral problems and sleep disturbance. STUDY DESIGN Questionnaires, sleep consultations, and sleep diaries were obtained in 20 children with SMS (9 girls, 11 boys aged 4 to 17 years). Actigraphy, electroencephalography, and the circadian variations of plasma melatonin, cortisol, and growth hormone were recorded in 8 patients. Early sleep onset, early sleep offset, and sleep attack indicated sleep disturbance. RESULTS All children with SMS had a phase shift of their circadian rhythm of melatonin. Time at onset of melatonin secretion was 6 AM +/- 2 (control group: 9 P.M. +/- 2). Peak time was 12 PM +/- 1 (control group: 3:30 AM +/- 1:30), and melatonin offset was at 8 PM +/- 1 (control group: 6 AM +/- 1). Behavioral problems correlated with the inverted circadian rhythm of melatonin. CONCLUSION Considering that clock genes mediate the generation of circadian rhythms, we suggest that haploinsufficiency for a circadian system gene mapping to chromosome 17p11.2 may cause the inversion of the circadian rhythm of melatonin in SMS.

[1]  Yoshiyuki Sakaki,et al.  Circadian oscillation of a mammalian homologue of the Drosophila period gene , 1997, Nature.

[2]  P Lavie,et al.  Melatonin possesses time-dependent hypnotic effects. , 1994, Sleep.

[3]  D Dawson,et al.  Melatonin and sleep in humans , 1993, Journal of pineal research.

[4]  F Greenberg,et al.  Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. , 1996, American journal of human genetics.

[5]  J E Jan,et al.  Use of melatonin in the treatment of paediatric sleep disorders , 1996, Journal of pineal research.

[6]  F Greenberg,et al.  Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). , 1998, American journal of medical genetics.

[7]  C McCluggage,et al.  Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) , 1996, American journal of medical genetics.

[8]  J. Lupski,et al.  Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the smith-magenis syndrome critical region in 17p11.2. , 1999, Genomics.

[9]  P. Lavie,et al.  Sleep-inducing effects of exogenous melatonin administration. , 1998, Sleep medicine reviews.

[10]  A. Cavallo Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. , 1992, Neuroendocrinology.

[11]  J. Opitz,et al.  Interstitial deletion of (17)(p11.2p11.2) in nine patients. , 1986, American journal of medical genetics.

[12]  Izzo,et al.  SUPPRESSION OF MELATONIN SECRETION IN SOME BLIND PATIENTS BY EXPOSURE TO BRIGHT LIGHT , 2001 .

[13]  R. Moore,et al.  Circadian rhythms: basic neurobiology and clinical applications. , 1997, Annual review of medicine.

[14]  Lorraine Potocki,et al.  Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome , 2000, Journal of medical genetics.

[15]  M. Karásek,et al.  Melatonin in humans. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[16]  P. Patel,et al.  Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome. , 1999, American journal of medical genetics.

[17]  L. Wing,et al.  Sleep problems in handicapped children: a preliminary study. , 1986, Journal of child psychology and psychiatry, and allied disciplines.

[18]  E. Koonin,et al.  Pineal Serotonin N-Acetyltransferase: Expression Cloning and Molecular Analysis , 1995, Science.

[19]  F. Greenberg,et al.  Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). , 1998, American journal of medical genetics.

[20]  S. Kahng,et al.  SLEEP PATTERNS IN CHILDREN AND YOUNG ADULTS WITH MENTAL RETARDATION AND SEVERE BEHAVIOR DISORDERS , 1996, Developmental medicine and child neurology.

[21]  Gregor Eichele,et al.  A Differential Response of Two Putative Mammalian Circadian Regulators, mper1 and mper2, to Light , 1997, Cell.